Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study of LY3471851 in Participants With Psoriasis

ClinicalTrials.gov ID: NCT04119557

Public ClinicalTrials.gov record NCT04119557. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Patients With Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to learn more about the safety of LY3471851 when given by injection just under the skin to participants with psoriasis. The study will last up to 48 weeks and may include up to 23 visits to the study center.

Study identification

NCT ID
NCT04119557
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Nektar Therapeutics
Industry
Enrollment
30 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 25, 2019
Primary completion
Jul 20, 2021
Completion
Jul 20, 2021
Last update posted
Feb 19, 2024

2019 – 2021

United States locations

U.S. sites
24
U.S. states
13
U.S. cities
23
Facility City State ZIP Site status
Arkansas Research Trials, LLC North Little Rock Arkansas 72117
California Dermatology & Clinical Research Institute Encinitas California 92024
Center For Dermatology Clinical Research, Inc. Fremont California 94538
Therapeutics Clinical Research San Diego California 92123
Clinical Science Institute Santa Monica California 90404
Florida Academic Centers Research and Education, LLC Coral Gables Florida 33134
Miami Dermatology and Laser Research Miami Florida 33173
ForCare Clinical Research Tampa Florida 33613-1244
Medical Dermatology Specialists Sandy Springs Georgia 30328
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250
Skin Sciences Louisville Kentucky 40217
Forefront Research Louisville Kentucky 40241
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48047
Derm Center Troy Michigan 48084
Central Dermatology PC St Louis Missouri 63117
ActivMed Practices and Research Portsmouth New Hampshire 03801
Remington-Davis, Inc Columbus Ohio 43215
Unity Clinical Research Oklahoma City Oklahoma 73118
Paddington Testing Company Inc Philadelphia Pennsylvania 19103
DermDox Centers for Dermatology Sugarloaf Pennsylvania 18249
Studies in Dermatology, LLC Cypress Texas 77433
Rodgers Dermatology Frisco Texas 75034
Progressive Clinical Research San Antonio Texas 78229
Complete Dermatology Sugar Land Texas 77478

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04119557, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 19, 2024 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04119557 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →